Clinical Trial Update: Bevacizumab + Triplet Treatment for Untreated With Chemotherapy Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating bevacizumab in combination with a triplet chemotherapy regimen for untreated metastatic colorectal cancer; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)

Snippet

Sponsor: Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan | Conditions: Metastatic Colorectal Cancer | Phase 2 | Status: COMPLETED